Boji Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without any false records, misleading statements, or significant omissions.
300404SZSE
Announcement of Resolutions from the 19th Meeting of the 5th Board of Directors
✨ AI Summary
The 19th meeting of the 5th Board of Directors of Boji Pharmaceutical Technology Co., Ltd. was held on February 24, 2026. The board approved a plan to repurchase shares through centralized bidding, with a maximum of 2,667,000 shares to be sold, representing 0.69% of the total share capital. The sale will occur within six months after the announcement, starting 15 trading days post-announcement.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.